Vivos Therapeutics, Inc. (VVOS)
USD 2.57
(0.0%)
USD 2.57
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -16.67 Million USD | 31.84% |
| 2022 | -24.36 Million USD | -31.31% |
| 2021 | -19.54 Million USD | -65.71% |
| 2020 | -11.24 Million USD | -14.66% |
| 2019 | -9.86 Million USD | -26.92% |
| 2018 | -7.72 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.15 Million USD | 11.46% |
| 2024 Q2 | -1.79 Million USD | 50.78% |
| 2023 Q2 | -3.5 Million USD | 56.25% |
| 2023 Q1 | -8 Million USD | -70.03% |
| 2023 FY | - USD | 31.84% |
| 2023 Q4 | -4.13 Million USD | 13.64% |
| 2023 Q3 | -4.78 Million USD | -36.72% |
| 2022 Q3 | -5.23 Million USD | 21.7% |
| 2022 Q2 | -6.68 Million USD | 15.94% |
| 2022 Q1 | -7.94 Million USD | -10.07% |
| 2022 FY | - USD | -31.31% |
| 2022 Q4 | -4.7 Million USD | 10.0% |
| 2021 Q1 | -3.22 Million USD | 46.79% |
| 2021 FY | - USD | -65.71% |
| 2021 Q2 | -3.84 Million USD | -19.43% |
| 2021 Q3 | -5.25 Million USD | -36.49% |
| 2021 Q4 | -7.22 Million USD | -37.5% |
| 2020 Q2 | -1.21 Million USD | 48.43% |
| 2020 FY | - USD | -14.66% |
| 2020 Q4 | -6.05 Million USD | -274.36% |
| 2020 Q3 | -1.61 Million USD | -33.11% |
| 2020 Q1 | -2.35 Million USD | 1.3% |
| 2019 Q2 | -2.3 Million USD | 0.0% |
| 2019 Q4 | -2.38 Million USD | 16.69% |
| 2019 Q3 | -2.86 Million USD | -24.21% |
| 2019 Q1 | -2.3 Million USD | 0.0% |
| 2019 FY | - USD | -26.92% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -23.638% |
| Cerus Corporation | -26.53 Million USD | 37.161% |
| OrthoPediatrics Corp. | -8.38 Million USD | -98.962% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -58.893% |
| Talis Biomedical Corporation | -66.04 Million USD | 74.752% |
| Inogen, Inc. | -45.67 Million USD | 63.495% |
| Spectral AI, Inc. | -12.26 Million USD | -35.989% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 65.037% |
| CVRx, Inc. | -38.73 Million USD | 56.947% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -372.647% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -37.73% |
| Orthofix Medical Inc. | -86.98 Million USD | 80.83% |
| Venus Concept Inc. | -26.11 Million USD | 36.143% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 66.497% |
| Bioventus Inc. | -23.07 Million USD | 27.72% |
| BrainsWay Ltd. | -2.31 Million USD | -621.549% |
| Envoy Medical, Inc. | -18.23 Million USD | 8.57% |
| electroCore, Inc. | -17.76 Million USD | 6.109% |
| IceCure Medical Ltd | -15.25 Million USD | -9.323% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 66.483% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 1.072% |
| MaxCyte, Inc. | -44.12 Million USD | 62.212% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -41.843% |
| Nexalin Technology, Inc. | -5.69 Million USD | -192.953% |
| PAVmed Inc | -75.74 Million USD | 77.984% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 68.981% |
| RxSight, Inc. | -41.03 Million USD | 59.366% |
| Sight Sciences, Inc. | -49.41 Million USD | 66.255% |
| SI-BONE, Inc. | -34.44 Million USD | 51.591% |
| TELA Bio, Inc. | -40.63 Million USD | 58.962% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 71.397% |
| Treace Medical Concepts, Inc. | -39 Million USD | 57.252% |
| LivaNova PLC | 39.01 Million USD | 142.739% |
| 908 Devices Inc. | -34.02 Million USD | 50.992% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 84.922% |
| Nemaura Medical Inc. | -7.28 Million USD | -128.83% |
| NeuroPace, Inc. | -22.83 Million USD | 26.973% |
| LENSAR, Inc. | -8.71 Million USD | -91.359% |
| Apyx Medical Corporation | -18.11 Million USD | 7.934% |
| Cutera, Inc. | -136.56 Million USD | 87.789% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -393.343% |
| BioSig Technologies, Inc. | -28.15 Million USD | 40.766% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 762.758% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 20.554% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 104.347% |
| Axonics, Inc. | 7.77 Million USD | 314.469% |
| Outset Medical, Inc. | -153.78 Million USD | 89.157% |
| IRIDEX Corporation | -7.44 Million USD | -123.886% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 83.001% |
| IRadimed Corporation | 20.8 Million USD | 180.166% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -106.835% |
| INVO Bioscience, Inc. | -6.88 Million USD | -142.368% |
| Telesis Bio, Inc. | -40.49 Million USD | 58.82% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 145.464% |
| Varex Imaging Corporation | 67.2 Million USD | 124.814% |
| Quipt Home Medical Corp. | 44.07 Million USD | 137.837% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -53.404% |
| Pulmonx Corporation | -55.09 Million USD | 69.732% |
| Dynatronics Corporation | -976 Thousand USD | -1608.49% |
| Modular Medical, Inc. | -17.1 Million USD | 2.502% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -15.119% |
| Semler Scientific, Inc. | 23.58 Million USD | 170.69% |
| InMode Ltd. | 196.28 Million USD | 108.495% |
| Bruker Corporation | 599 Million USD | 102.784% |
| Cytosorbents Corporation | -28.81 Million USD | 42.122% |
| DexCom, Inc. | 916.7 Million USD | 101.819% |
| Align Technology, Inc. | 799.03 Million USD | 102.087% |
| Viveve Medical, Inc. | -20.61 Million USD | 19.12% |
| ZimVie Inc. | 91.07 Million USD | 118.309% |
| Movano Inc. | -29.12 Million USD | 42.747% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -278.29% |
| Nexalin Technology, Inc. | -5.69 Million USD | -192.953% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -372.647% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 91.434% |
| Profound Medical Corp. | -27.12 Million USD | 38.522% |
| Insulet Corporation | 323.6 Million USD | 105.153% |
| enVVeno Medical Corporation | -25.01 Million USD | 33.348% |
| Surmodics, Inc. | 1.18 Million USD | 1503.62% |
| iCAD, Inc. | -6.56 Million USD | -153.998% |
| Nuwellis, Inc. | -16.35 Million USD | -1.95% |
| Biotricity, Inc. | -8.82 Million USD | -88.882% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 82.785% |
| Aethlon Medical, Inc. | -11.84 Million USD | -40.728% |
| InspireMD, Inc. | -20.91 Million USD | 20.257% |
| PAVmed Inc. | -75.74 Million USD | 77.984% |
| BIOLASE, Inc. | -15.13 Million USD | -10.146% |
| Beyond Air, Inc. | -59.03 Million USD | 71.752% |
| FONAR Corporation | 28.25 Million USD | 159.023% |
| AxoGen, Inc. | -13.32 Million USD | -25.113% |
| Vivani Medical, Inc. | -26.6 Million USD | 37.331% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 167.948% |
| Inari Medical, Inc. | 7.11 Million USD | 334.43% |
| UFP Technologies, Inc. | 72.74 Million USD | 122.923% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -392.5% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -170.874% |
| Tenon Medical, Inc. | -15.52 Million USD | -7.387% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -9.23% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 59.796% |
| AdaptHealth Corp. | -171.09 Million USD | 90.254% |
| Sintx Technologies, Inc. | -6.6 Million USD | -152.652% |
| NanoVibronix, Inc. | -3.43 Million USD | -385.444% |
| Quanterix Corporation | -38.08 Million USD | 56.22% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -53.404% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 55683.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 93.986% |
| TransMedics Group, Inc. | -7.6 Million USD | -119.321% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 23.386% |
| NeuroMetrix, Inc. | -7.09 Million USD | -134.998% |
| Hyperfine, Inc. | -47.06 Million USD | 64.567% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 71.401% |
| Biomerica, Inc. | -5.99 Million USD | -178.241% |
| Bone Biologics Corporation | 479.57 Thousand USD | 3577.059% |
| AVITA Medical, Inc. | -39.56 Million USD | 57.857% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -81.785% |
| Silk Road Medical, Inc | -45.08 Million USD | 63.01% |